News | Neuro Imaging | May 10, 2018

Impaired Brain Pathways May Cause Attention Problems After Stroke

Patients with chronic stroke showed prolonged reaction time during imaging assessment

Impaired Brain Pathways May Cause Attention Problems After Stroke

May 10, 2018 — Damage to some of the pathways that carry information throughout the brain may be responsible for attention deficit in patients who have had a subcortical stroke in the brain's right hemisphere. These conclusions are drawn from a study published online in the journal Radiology. Researchers hope the findings may provide a measure for selecting suitable patients for early interventions aimed at reducing cognitive decline following stroke.

A stroke may affect cortical regions of the cerebral cortex, which includes the gray matter that lines the surface of the brain, or it may affect brain regions below the cortex, including white matter tracts connecting different regions of the brain. A stroke affecting brain structures below the cortex is known as a subcortical stroke.

More than one-third of patients experience cognitive decline after a stroke, including attention deficit, which can affect and impair the patient's ability to carry out routine activities of daily living.

"Impairment of attention has been observed in patients with both cortical and subcortical stroke," said senior study author Chunshui Yu, M.D., from the Department of Radiology at Tianjin Medical University General Hospital in Tianjin, China. "In cortical stroke, the direct involvement of cortical regions associated with attention may account for the deficit. However, the parts of the nervous and brain systems underlying attention deficit in subcortical stroke remain largely unknown."

To investigate the mechanisms underlying attention deficit in chronic subcortical stroke, Yu and colleagues combined voxel-based lesion-symptom mapping (VLSM) and diffusion tensor tractography (DTT) in two sets of patients: One group of 49 patients (32 men and 17 women between the ages of 40 and 71) after subcortical stroke, and 52 control patients (30 men and 22 women, age 40-68). VLSM is a method of analyzing relationships between tissue damage and behavioral deficits, and DTT is a magnetic resonance imaging (MRI) technique that allows for 3-D visualization of specific white matter tracts in the brain.

A modified version of the attention network test was used to assess visual attention function. VLSM was used to identify lesion locations related to attention deficit in the stroke patients. Then DTT was used to determine the responsible impaired brain connections at the chronic stage (> 6 months post-stroke).

The results showed that compared to the controls, patients with chronic stroke exhibited prolonged reaction time during the attention task. VLSM revealed that having an acute stroke lesion in the right caudate nucleus and nearby white matter was correlated to the prolonged reaction time. DTT showed that the responsible lesion was located in the right thalamic- and caudate-prefrontal pathways in controls.

The right brain damage subgroup had significantly decreased fractional anisotropy (FA) in these pathways, which were correlated with the prolonged reaction time. FA provides a way to measure diffusion occurring within a region of the brain. FA is typically higher in brain regions of high organization. Reductions in FA have been previously associated with advancing age and in cases of cognitive impairment.

"The impairment of the right thalamic- and caudate-prefrontal pathways was consistently associated with attention deficit in patients with right subcortical stroke," Yu said. "Based on this association, one can estimate which patients with stroke would be more likely to develop into long-term persisting attention deficit by evaluating the lesion-induced damage to these pathways."

For more information: www.pubs.rsna.org

 

Related Content

Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...